Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation

NCT06565247 is registered in ClinicalTrials.gov with Region Västerbotten as lead sponsor.

NCT NCT06565247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06565247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation
Lead sponsor
Region Västerbotten
Phase
Phase 3
Overall status
Recruiting
Start date
October 14, 2024
Completion date
December 31, 2031
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer